Published in Vaccine Weekly, October 26th, 1998
According to the inventor, Dr. Hans J. Hansen, Immunomedics, "The invention is called a 'multi-stage cascade boosting vaccine,' because it combines two vaccine technologies with certain cytokines, whereby the anticancer or anti-infection antibodies are given first, followed by anti-idiotype vaccines that mimic the cancer or infectious agent against which immunity is desired."
The patent also describes the enhancement of cellular immunity, involving T-lymphocytes,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly